ARCHIVES

PDQ Evaluation to Cost NCI More Than Reported

This article is from The Cancer Letter archive.

Vol. 16 No. 26 | June 29, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

In Brief: Krakoff moves To Scotland; Salmon Wins Waldenstrom Award; ONS endorses Reform

November 5, 1993

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block

March 18, 1977